Periciazine

Revision as of 16:55, 20 August 2015 by WikiBot (talk | contribs) (Protected "Periciazine": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Periciazine
Clinical data
Pregnancy
category
  • AU: C
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
MetabolismHepatic (mostly via conjugation)[1]
Elimination half-life12 h[1]
ExcretionRenal[1]
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC21H23N3OS
Molar mass365.49 g/mol
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Periciazine

Articles

Most recent articles on Periciazine

Most cited articles on Periciazine

Review articles on Periciazine

Articles on Periciazine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Periciazine

Images of Periciazine

Photos of Periciazine

Podcasts & MP3s on Periciazine

Videos on Periciazine

Evidence Based Medicine

Cochrane Collaboration on Periciazine

Bandolier on Periciazine

TRIP on Periciazine

Clinical Trials

Ongoing Trials on Periciazine at Clinical Trials.gov

Trial results on Periciazine

Clinical Trials on Periciazine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Periciazine

NICE Guidance on Periciazine

NHS PRODIGY Guidance

FDA on Periciazine

CDC on Periciazine

Books

Books on Periciazine

News

Periciazine in the news

Be alerted to news on Periciazine

News trends on Periciazine

Commentary

Blogs on Periciazine

Definitions

Definitions of Periciazine

Patient Resources / Community

Patient resources on Periciazine

Discussion groups on Periciazine

Patient Handouts on Periciazine

Directions to Hospitals Treating Periciazine

Risk calculators and risk factors for Periciazine

Healthcare Provider Resources

Symptoms of Periciazine

Causes & Risk Factors for Periciazine

Diagnostic studies for Periciazine

Treatment of Periciazine

Continuing Medical Education (CME)

CME Programs on Periciazine

International

Periciazine en Espanol

Periciazine en Francais

Business

Periciazine in the Marketplace

Patents on Periciazine

Experimental / Informatics

List of terms related to Periciazine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Periciazine (INN), also known as pericyazine (BAN) or propericiazine, is a drug that belongs to the phenothiazine class of typical antipsychotics.

Pericyazine is not approved for sale in the United States. It is commonly sold in Canada under the tradename Neuleptil and in United Kingdom and Australia under the tradename Neulactil.[2]

Medical Uses

The primary uses of pericyazine include in the short-term treatment of severe anxiety or tension and in the maintenance treatment of psychotic disorders such as schizophrenia.[1]

Periciazine has also been studied in the treatment of opioid dependence.[3]

Adverse effects

Pericyazine is a rather sedating and anticholinergic antipsychotic, and despite being classed with the typical antipsychotics, its risk of extrapyramidal side effects is comparatively low.[4] It has a relatively high risk of causing hyperprolactinaemia and a moderate risk of causing weight gain and orthostatic hypotension.[4]

References

  1. 1.0 1.1 1.2 1.3 "NEULACTIL PRODUCT INFORMATION" (PDF). TGA eBusiness Services. sanofi-aventis australia pty ltd. 13 September 2011. Retrieved 2 November 2013.
  2. Pericyazine. Martindale: The Complete Drug Reference. The Royal Pharmaceutical Society of Great Britain. 23 September 2011. Retrieved 2 November 2013.
  3. Sivolap IuP, Savchenkov VA (1999). "[The use of neuroleptics in treating opiate dependence]". Zh Nevrol Psikhiatr Im S S Korsakova (in Russian). 99 (6): 29–34. PMID 10441864.
  4. 4.0 4.1 "Approximate relative frequency (not intensity) of common adverse effects of antipsychotics (Table 8.21) [NB1]". eTherapeutic Guidelines complete. Therapeutic Guidelines Limited. February 2013. Retrieved 2 November 2013.

External links


Template:Catecholaminergics

Template:Tricyclics


Template:Nervous-system-drug-stub